Cargando…
Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related deaths. Immunotherapy activates the patient’s immune system to identify and kill cancer cells. Moreover, memory immune cells are formed that prevent the recurrence of cancer, leading to durable responses. However, only 20% of patient...
Autores principales: | Khalil, Roukiah, Green, Ryan J., Sivakumar, Kavya, Varandani, Payal, Bharadwaj, Srinivas, Mohapatra, Shyam S., Mohapatra, Subhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295988/ https://www.ncbi.nlm.nih.gov/pubmed/37370701 http://dx.doi.org/10.3390/cancers15123089 |
Ejemplares similares
-
Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019) -
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021) -
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
por: Green, Ryan, et al.
Publicado: (2022) -
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway
por: Green, Ryan, et al.
Publicado: (2019) -
SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
por: McGill, Andrew R., et al.
Publicado: (2021)